Succinylcholine Chloride 200 mg/10 mL Injection Solution 10 mL
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
1,103 recalls, newest first
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Subpotent Drug: Product has an an out of specification in iron assay analysis found during 18 month stability testing.
Failed Stability Specifications; out-of specification value for homogeneity / phase separation.
Marketed Without An Approved NDA/ANDA: The product contains undeclared sibutramine. The presence of sibutramine, a previously approved controlled substance that was removed from the U.S. market in October 2010 for safety reasons, in this tainted product renders it an unapproved drug for which safety and efficacy have not been established and therefore subject to recall.
Microbial Contamination of Non-Sterile Products: bulk solution tested positive for the presence of the bacteria, Burkholderia cepacia.